PharMerica Corp. (PMC) Trading Down 3.1%
PharMerica Corp. (NYSE:PMC) shares fell 3.1% on Wednesday . The company traded as low as $25.00 and last traded at $25.08, with a volume of 137,918 shares traded. The stock had previously closed at $25.89.
A number of brokerages have weighed in on PMC. TheStreet downgraded shares of PharMerica Corp. from a “buy” rating to a “hold” rating in a research report on Monday, May 9th. Zacks Investment Research upgraded shares of PharMerica Corp. from a “hold” rating to a “strong-buy” rating and set a $30.00 price target for the company in a research report on Thursday, May 12th. Barrington Research restated an “outperform” rating and set a $34.00 price target (up previously from $30.00) on shares of PharMerica Corp. in a research report on Tuesday, May 10th. Finally, Bank of America Corp. assumed coverage on shares of PharMerica Corp. in a research report on Tuesday, June 7th. They set a “buy” rating and a $32.00 price target for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company’s stock. PharMerica Corp. has an average rating of “Buy” and an average target price of $31.57.
The stock’s 50 day moving average is $24.96 and its 200 day moving average is $24.58. The firm has a market capitalization of $791.70 million and a P/E ratio of 26.5854.
PharMerica Corp. (NYSE:PMC) last announced its quarterly earnings data on Tuesday, August 9th. The company reported $0.47 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.47. The company earned $519.60 million during the quarter, compared to analyst estimates of $508.31 million. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the business earned $0.48 EPS. Equities analysts expect that PharMerica Corp. will post $2.01 earnings per share for the current year.
An institutional investor recently raised its position in PharMerica Corp. stock. Wells Fargo & Company MN increased its stake in shares of PharMerica Corp. (NYSE:PMC) by 3.6% during the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 305,474 shares of the company’s stock after buying an additional 10,609 shares during the period. Wells Fargo & Company MN owned 1.00% of PharMerica Corp. worth $10,692,000 at the end of the most recent reporting period.
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.